Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.3302A>G | p.Tyr1101Cys | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TAT | Tyr | TGT | Cys | A->G | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #12 | conserved AA in cbEGF-like | No | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): none Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
0.83 | 0.00 (pathogenous) | 100 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
GER03HAN F0014 I07 | Proband | Male | de novo | 13 years old | GERMANY |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom | Severity |
C-Asc. aortic dilatation | |
O-Ectopia lentis | bilateral |
S-Arachnodactyly (M) | |
S-Dolichostenomelia | |
S-Increased body length | |
S-Scoliosis > 20° (M)(1) | |
SI-Significant striae atrophicae (m)(1) |
Reference ID | PubMed ID | Reference |
107 | 12402346 | Rommel K, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. "Mutation screening of the fibrillin-1 (FBN1) gene in 76 unrelated patients with Marfan syndrome or Marfanoid features leads to the identification of 11 novel and three previously reported mutations". Hum Mutat. 2002 Nov;20(5):406-7. |